daratumumab
janssen
interested in the role of nk cells in cd38 antibody therapy response in mm? watch back my oral presentation of yesterday on the reduction of cytotoxic nk cells in a subset of ndmm patients impacting outcome after daratumumab therapy. #ims2022 #nkcells 
MD | PhD Candidate Hematology @Erasmus MC | Research Fellow @DanaFarber | #NK cell biology and Immunology in Multiple Myeloma